Proactive Text Messaging Outreach for Tobacco Cessation Among Patients With COPD Who Smoke: A Randomized Pilot Authors: Anne C Melzer, Adam Kaplan, Megan Campbell, David Nelson, Hildi Hagedorn, Steven S Fu Published: 2025 ABSTRACT AbstractObjectiveTo assess the feasibility, acceptability, and treatment outcomes of a proactive motivational texting program with phone-based care coordination among people with chronic obstructive pulmonary disease who smoke (PCWS).DesignRandomized, unblinded pilot among PCWS, regardless of intention to quit smoking.MethodsConsenting participants were randomized 2:1 to the intervention vs a mailed offer of cessation services. Intervention consisted of a 12-week tapering-frequency motivational texting protocol, adapted from an existing clinically available protocol. Tailoring included COPD-specific messages and the option for phone-based care coordination, connecting participants to their choice of tobacco treatments. Primary outcomes were feasibility and treatment participation through 6 months. Results were analyzed using logistic regression, adjusted for imbalanced baseline characteristics deemed a priori likely to impact cessation behaviors.ResultsOf 697 invited, 125 enrolled and were randomized (83 intervention and 42 control) and 148 were ineligible, for an enrollment rate of 22.8% among eligible individuals. Primary reasons for ineligibility were: already quit or engaged in cessation efforts (n = 79), no text-capable phone (n = 50). Participants were older (mean age 68.4 years), predominantly male (82.3%) and white (78.2%). Most participants in the intervention arm completed the texting protocol (71/83, 85.5%) and responded to it at least once (63/83, 75.9%). Cessation outcomes were not statistically significant but favored the intervention. More participants in the intervention arm utilized any treatment (34.9% vs 21.9%, OR 2.37, 95%CI 0.94-6.40); 11 (13.2%) vs 1 (2.4%) (P = 0.053) completed a care coordination call. Acceptability of the texting protocol was high with 80.6% of participants finding the content relevant and 69.4% indicating they would recommend it. There were no identified harms. Study has completed all study procedures.ConclusionIn this randomized pilot of a proactive, motivational texting program for PCWS, we found evidence of feasibility, acceptability, and possible benefits for cessation outcomes. Such a program is low burden and may be suitable for both future research and broad use.Keywords: tobacco cessation treatment, COPD, electronic health communication, proactive patient engagement, smoking cessation Introduction Chronic obstructive pulmonary disease (COPD) remains a leading cause of morbidity and mortality, with most cases attributable to cigarette smoking. Historically, military personnel and Veterans have high rates of tobacco use, and Veterans suffer disproportionately from COPD. 1 Because most cases of COPD are attributable to smoking, patients with COPD smoke at rates double the national average,e 2 with 30%–40% still smoking.3,4 Quitting smoking is beneficial even in cases of advanced disease, 5 leading to improved symptoms2,6 and decreased risk of death from multiple smoking-related causes.5,7,8 Patients with COPD who smoke may be prompted to quit by the presence of respiratory symptoms, which may increase motivation to participate in treatment.9,10 They also often have significant barriers to cessation including high levels of addiction to nicotine, 11 low socioeconomic status12,13 and high burden of medical and psychiatric comorbidities. 14 Many have low motivation to quit, while others are motivated to quit, but are hampered in their success by a lack of self-efficacy 15 and quit confidence. 16 Despite these potential barriers, evidence suggests that patients with COPD can quit successfully at rates similar to patients in general if they receive the guideline-recommended combination of counseling and medication.17,18 Healthcare settings play a key role in connecting patients to cessation services. About 80% of patients with COPD seen in clinics receive brief advice, but few engage in supported quit attempts. 19 Therefore, motivating patients to quit and connecting them to treatment remains challenging in the context of sporadic visits when both clinicians and patients have competing clinical priorities. The motivation to quit or cut down can change rapidly, making every patient contact an important opportunity to address smoking behaviors. Proactive patient engagement is an effective method for increasing participation in tobacco treatment and cessation. Proactive patient engagement involves systematically identifying and contacting an individual outside of a routine clinic visit and providing an intervention to boost treatment participation. It has been found to be effective for increasing smoking cessation in a number of patient populations (eg, hospitalized patients,20,21 Veterans in primary care 22 and mental health clinics 23 ). Effective methods include live phone calls, interactive voice response systems, mailed materials and patient portal messages. While effective, proactive outreach is rarely implemented, in part due to perceived high burden on the health system with more intensive outreach methods. 24 Information and communication technology (ICT) such as text messaging and patient portals are increasingly used in healthcare, 25 allowing for broad reach with low cost. Use of technology among older individuals has rapidly increased and ICT is now a key part of health promotion. Many studies confirm that text messaging protocols can boost successful cessation among individuals making a quit attempt,26-29 and these approaches are supported by a Cochrane systematic review. 30 Our goal was to develop and test a protocol for proactive tobacco outreach using text messaging, tailored to patients with COPD who smoke but are not already engaged in a quit attempt. Our primary goal was to assess the feasibility and acceptability of the program and to examine early outcomes of treatment engagement and cessation to generate estimated effect sizes for future large-scale studies. Methods Study Design and Setting We performed a pragmatic 31 randomized feasibility pilot of the proactive motivational texting program. The study was conducted at the Minneapolis VA Health Care System (VAHCS) including the main medical center and 14 affiliated community-based clinics. This encompasses a highly rural catchment area including Minnesota and Western Wisconsin. Participants were enrolled remotely from March to December 2023. This study was approved by the Minneapolis VA IRB (#1708415) and registered on https://www.clinicaltrials.gov (NCT04462289). Because the study was fully remote and minimal risk, patients were apprised of the elements of informed consent by phone prior to enrollment under a waiver of documentation of informed consent. Subjects and Recruitment Potentially eligible participants were identified using the electronic health record (EHR) if they met the following criteria: 2 or more ICD-10 codes for COPD in the past 2 years at any VA healthcare system, a visit to primary care or pulmonary medicine at the Minneapolis VAHCS with in the past 18 months, last tobacco assessment indicated current smoking, not enrolled in tobacco treatment, not on hospice or under treatment for malignancy or dementia. Our facility cares for predominantly white males; therefore we oversampled women (12.5%) and racial or ethnic minorities (25%). Potential participants were mailed an opt-out letter. They were then contacted by phone to confirm eligibility and offer enrollment. Participants were excluded during the call if they had already quit smoking, were in a cessation program, lacked a text-capable phone, or declined participation. Participants were enrolled regardless of intention to quit smoking. Consenting individuals were enrolled into the VA’s ‘Annie’ texting platform, the system through which the intervention was delivered, then randomized 2:1 to the intervention and control arms. Randomization utilized permuted blocks of size 3 and 6 and was stratified by female/male and minoritized race or ethnicity. Intervention We follow published recommendations for reporting proactive outreach intervention studies. 32 To enhance scalability, we adapted a clinically available motivational texting program for tobacco treatment engagement. The program was delivered using the ‘Annie’ platform. ‘Annie’ is the VA’s clinical texting system, designed to support patient self-management protocols. Base Protocol The texting program had been developed by a group of psychologists and patient educators and was available for use by any clinician in the ‘Annie’ database of protocols. The protocol was delivered over 12 weeks, with greater frequency at the beginning (daily message) and diminishing frequency during subsequent weeks (twice weekly message). The content of the messages included informational statements (eg, “Stopping smoking is the most important thing you can do for your lung health. Even cutting down can improve symptoms like cough and wheezing.”) and assessments of readiness to quit or importance of quitting. Participants were asked weekly for the first 8 weeks, then biweekly, if they were ready to set a quit date; those indicating ‘quit yes’ were encouraged to enroll in cessation support by calling the VA quitline or their primary care provider. Tailored Protocol Based on a mixed methods assessment, 32 we tailored the intervention to the needs of our patient population. We collaborated with the Minneapolis VA Learning and Technology Annie Lead to create the adapted version of the texting protocol. Changes included: COPD-specific information, tips/quotes from Veterans who successfully quit, the option to text or call back and participate in live phone-based care coordination, and offering several choices for cessation programs. We obtained quotes from patients with COPD who had successfully quit, obtained from participants in tobacco treatment groups and pulmonary clinics. We included the 11 quotes ranked most highly on a survey of Veterans with COPD who smoke. In addition to general information about how to access quit resources (eg, call the VA Quitline, contact primary care), participants were encouraged to call the coordinator for a motivational discussion and connection to treatment options. Alternatively, if they responded to a text that they wanted to quit (‘quit yes’), this information was displayed in the Annie clinician-facing platform. These participants were contacted within approximately 2 business days to offer cessation services. Care coordination was conducted by phone by the research coordinator using a script offering the most intensive options (group counseling class with pharmacist medication management) to the least (VA app or texting program). (See Appendix A for script). Appropriate referrals were placed in the EHR. Participants could terminate the protocol at any time. The texting protocol is available in the VA Annie Library in Midwest region. Control The control arm received a mailed offer with information about cessation services, providing the same phone number to call for care coordination. All participants in both arms continued to have access to the tobacco treatment clinics and quitline services that were available to all patients via their clinical teams. Participants could be referred to these services by any clinicians or through the annual tobacco ‘clinical reminder’. This reminder prompts clinic staff to update smoking information and offer cessation services at one health-promotion visit each year. Data Collection Participants completed a brief baseline survey, either electronically via Qualtrics or during their initial phone intake. Surveys assessed demographics, health information, 33 smoking behaviors, prior tobacco treatments and cessation attempts, quit confidence, electronic health literacy 34 and views of tobacco treatments. Participants were surveyed again via Qualtrics 6 months after randomization. Participants who did not complete the survey after two electronic messages were contacted to complete a phone survey. Interactions with the texting program (eg, responses to queries, requests to ‘stop’) were extracted from the Annie platform. Participants were paid $20 following baseline survey and $20 following 6-month survey. Data team was blinded to treatment arm. Data team was provided a de-identified data set for analysis. Outcomes Six-month outcomes were assessed by self-report. Our primary outcomes were feasibility of enrollment, protocol completion and interaction, and acceptability of the texting protocol. Our primary outcome was any self-reported tobacco treatment participation since randomization. Additional secondary outcomes included 7-day cessation, cutting down, a composite of quitting or cutting down, quit attempts, use of individual tobacco treatments, participation in care coordination, and change in contemplation ladder. Cutting down was defined as a drop in frequency from daily to non-daily or a drop in at least one category level of cigarettes per day (defined in 10 cigarettes per day increments). Quitting or cutting down was a composite of 7-day abstinence or cutting down. Statistical Analysis Our primary analysis compared treatment participation rates between the intervention arms using a multivariable logistic regression. We identified several contextually important variables that were imbalanced between arms with the potential to explain variability in our primary outcomes; these included participant education level operationalized as “some college or less” vs the reference “college graduate or more”; participant’s time frame to quit smoking at baseline operationalized as “otherwise” vs the reference “no time frame to quit”; and the participant having had a quit attempt in the past year operationalized as “I have tried to quit” vs the reference “I haven’t tried to quit”. These were included, along with intervention arm, as predictors in the regression analysis. We report the model estimated odds ratio, corresponding 95% confidence interval, and P-value for the Wald test for each of the predictors included in the model. Analyses used RStudio version 4.4.1 35 Results Recruitment and Enrollment Figure 1 shows the results of recruitment. 697 individuals received opt-out letters. Of those, 563 (80.7%) were reached by phone, 148 of whom were ineligible. The primary reasons for ineligibility were already quit or engaged in cessation program (n = 79) or lack of a text capable phone to receive the messaging protocol (n = 50). Of those found to be eligible on phone outreach, 125 were randomized for an enrollment rate of 22.8% among eligible individuals. Results of Recruitment. *Administratively Withdrawn Due to Incomplete Baseline Data (<10% Questions Answered) Participant Characteristics Table 1 summarizes demographics and clinical characteristics of randomized participants (n = 125), with one withdrawn leaving 124 for baseline analysis. Participants were predominantly older, white males. Nearly half resided in rural areas. Most had household income <$50,000. Tobacco use was heavy, with the mean more than 50 pack-years. Most participants texted daily, though electronic health literacy measured by the eHEALS was low to moderate. Most participants were pre-contemplative (“I don’t really want to stop”) or contemplative (I want to stop smoking but without a specific timeframe) per the quit ladder. Most characteristics were balanced, but several variables were imbalanced including: college or greater education (22.9% intervention vs 12.2% control), past-year quit attempts (43.5% intervention vs 65.9% control), no particular timeframe to quit (65.1% intervention vs 48.8% control), intending to quit in the next one or 3 months (20.5% intervention vs 36.6% control). Table 1.Baseline Characteristics by Intervention Arm. Values Presented are n (%) or Mean (Standard Deviation) (n = 124)Intervention (N = 83)Control (N = 41)Male68 (81.9%)35 (83.3%)Age68.9 (7.22)67.7 (9.90)Non-hispanic white71 (85.5%)33 (80.5%)Rural/highly rural37 (44.6%)19 (45.3%)Education a Less than high school3 (3.6%)2 (4.9%) High school graduate (12th grade)/GED23 (27.7%)15 (36.6%) Some college or vocational education38 (45.8%)19 (46.3%) College graduate/post-graduate19 (22.9%)5 (12.2%)What is your current household income? <$10,0003 (3.6%)2 (4.9%) $10,000 - $20,00018 (21.7%)4 (9.8%) $20,000 - $50,00030 (36.1%)20 (48.8%) ≥$50,00031 (37.3%)13 (31.7%) Electronic health literacy (E-HEALS b )24.8 (9.45)24.7 (9.48)Cigarettes per day 10 or fewer26 (31.3%)16 (39.0%) 10 to 2047 (56.6%)20 (48.8%) 21 or more10 (12.0%)5 (12.2%)Pack-years57.5 (28.65)56.7 (32.95)Attempted to quit in past year a 36 (43.4%)27 (65.9%)Past-year quit assistance26 (31.3%)13 (31.7%)No particular timeframe to quit a 54 (65.1%)20 (48.8%)Quit confidence (1-10)4.81 (2.51)4.68 (2.82)Heaviness of smoking index2.48 (1.42)2.41 (1.61)Quit ladder I don’t want to stop/I think I should stop smoking but don’t really want to25 (30.1%)14 (34.2%) I want to stop smoking but haven’t thought about when13 (15.7%)4 (9.8%) I really want to stop smoking, but I don’t know when I will16 (19.3%)6 (14.6%) I want to stop smoking and hope to soon12 (14.5%)2 (4.9%) I really want to stop smoking and intend to in the next 1 or 3 months a 19 (20.5%)15 (36.6%)Frequency of smoking Every day81 (97.6%)38 (92.7%) Some days2 (2.4%)3 (7.3%)Respiratory symptom questionnaire6.20 (3.93)5.85 (3.56)Self-reported health from 0-10055.6 (19.1)53.9 (17.0)Uses texting about every day64 (77.1%)33 (80.5%)aVariables identified with an * were imbalanced and considered for inclusion in adjusted models.bEHEALS: 8-40, 8 being very low e-health literacy. Pack years calculated as years of smoking times average cigarette count per day. Respiratory symptoms questionnaire: scale from 0 to 16, higher being more symptoms. Baseline Characteristics by Intervention Arm. Values Presented are n (%) or Mean (Standard Deviation) (n = 124) aVariables identified with an * were imbalanced and considered for inclusion in adjusted models. bEHEALS: 8-40, 8 being very low e-health literacy. Pack years calculated as years of smoking times average cigarette count per day. Respiratory symptoms questionnaire: scale from 0 to 16, higher being more symptoms. Interaction with the Texting Program and Care Coordination Successful completion of the 12-week protocol was high, with 71/83 (85.5%) in the intervention arm completing the 12-week protocol. Of those who did not complete it (n = 12), 4 requested to stop, 5 were dropped in error by the system, and 3 were dropped by the system due to repeated erroneous responses. Most participants responded to at least one query (n = 63, 75.9%), with a minority (n = 22, 26.5%) indicating an intention to set a quit date at least once. However, some responses (4/42 “quit yes” responses, 4/58 “quit no” responses) did not conform to the response format and were rejected by the system. These participants responded to the system with narrative text (eg, “not ready yet!”). Therefore, these responses were not displayed in the clinician-facing portal. Responsiveness to the prompts to set a quit date diminished over time. Following week 8, no participants responded to the quit date query (Figure 2). Responses to “Ready to Set a Quit Date?” by Week of Texting Protocol (N = 83) Acceptability Acceptability of the texting program was high. Among the 62 respondents, 50 (70.6%) agreed or strongly agreed that the content of the messages was understandable and relevant; 45 (72.6%) agreed or strongly agreed that the program was easy to use and navigate; and 43 (69.4%) would recommend the program to someone else. Approximately a third of participants (n = 21, 33.9%) felt that it motivated them to stop smoking. Cessation Support and Quit Behaviors Nonresponse to the 6-month follow-up survey was low (8%) and not differential between arms. Results favored the intervention arm but were not statistically significant. In unadjusted analyses for our primary outcome, more participants in the intervention arm used cessation services (34.9% vs 21.9.0%, P = 0.14). More completed a care coordination call 13.2% vs 2.4%, P = 0.053), quit smoking over a 7--day timeframe (9.6% vs 7.3%, P = 0.928), cut down in heaviness or frequency of smoking (30.1% vs 22%, P = 0.609), and quit or cut down (38.6% vs 29.3%, P = 0.399). Interestingly, fewer participants in the intervention arm had tried to quit for at least 24 hours (42% vs 51.2%, P = 0.789) and there was no apparent impact on moving up the quit ladder (27.7% vs 31.7%, P = 0.906). Among those who used quit support (n = 38), more participants in the intervention arm used combined behavioral and pharmacotherapy (13.7% vs 0%), though pharmacotherapy alone remained the most common treatment in both arms (69% intervention vs 88.9% control, P = 0.447). Among participants who used medications, single agent nicotine replacement was the most common (Table 2). In exploratory analyses in the intervention arm, when stratified by baseline pre-contemplative (‘no timeframe in mind to quit’) vs contemplative stage of change, fewer pre-contemplative participants used cessation support (31.5% vs 41.4%, P = 0.715), quit or cut down (33.3% vs 48.3%, P = 0.3), quit smoking (5.6% vs 17.2%, P = 0.197) and attempted to quit smoking (35.2% vs 55.2, P = 0.138). Table 2.Treatment Participation and Cessation Behaviors at 6 months (n = 124)Intervention (n = 83)Control (n = 41)P-valueUsed any quit support in the past 6 months29 (34.9%)9 (21.9%)0.14Completed a care coordination call11 (13.2%)1 (2.4%)0.053Moved upward on the quit ladder (if still smoking)23 (27.7%)13 (31.7%)0.906Attempted to quit35 (42%)21 (51.2%)0.789Cut down in heaviness or frequency25 (30.1%)9 (22.0%)0.6097-day abstinence8 (9.6%)3 (7.3%)0.928Quit or cut down32 (38.6%)12 (29.3%)0.399What quit support was used (ntot = 38)0.288 Medications alone20 (69%)8 (88.9%) Medications and cessation clinic or group class4 (13.7%)0 Cessation clinic or texting/app alone4 (13.7%)1 (11.1%)Medications used (ntot = 32)0.447 Single nicotine replacement15 (62.5%)4 (50%) Combination nicotine replacement4 (20%)3 (37.5%) Varenicline2 (10%)1 (12.5%) Bupropion (with or without NRT)2 (10%)0Combination nicotine replacement: short-acting nicotine and patch.NRT: Nicotine replacement therapy. Treatment Participation and Cessation Behaviors at 6 months (n = 124) Combination nicotine replacement: short-acting nicotine and patch. NRT: Nicotine replacement therapy. Adjusted Analyses We adjusted for imbalanced characteristics considered a priori to have an impact on cessation behaviors. We then assessed collinearity among these variables and identified a reduced set to use in the formal analysis. Overall, while not statistically significant, the effect of the intervention was an approximately two-fold increase in odds of using any tobacco dependence treatment (OR 2.37, 95% CI 0.94-6.4). We identified other positive impacts on cessation behaviors including: 7-day abstinence (OR 1.72 95% CI 0.42-8.69), cutting down (OR 2.00, 0.83-5.11), quitting or cutting down (OR 2.02 95% CI 0.84-5.13). There was no impact on moving up the quit ladder from baseline to 6 months follow-up (P = 0.431) (Table 3). Table 3.Adjusted Analyses Examining Cessation Behaviors and Participation in Quit Support (n = 109)*OR95% CIP-valueUsed quit support in the past 6 months2.370.94-6.400.074Cut down in heaviness or frequency2.000.83-5.110.1337-day abstinence1.720.42-8.690.464Quit or cut down2.020.84-5.130.126Moved upward on the quit ladder0.850.36-0.280.279*Models adjusted for educational attainment, timeframe to quit at baseline, past year quit attempt. Adjusted Analyses Examining Cessation Behaviors and Participation in Quit Support (n = 109)* *Models adjusted for educational attainment, timeframe to quit at baseline, past year quit attempt. Discussion In this randomized pilot of a proactive motivational texting program for patients with COPD who smoke, we found that the program was feasible and acceptable with high rates of completion of the 12-week protocol. While not statistically significant due to sample size limitations, the greater than 10% increase in use of cessation services and fairly high participation in care coordination calls suggests a positive impact. Recruitment was limited primarily by lack of interest in participation, though a significant number (8.8%) of potential participants lacked a text-capable phone. This finding is consistent with our prior research that identified an ongoing ‘technology gap’ in this population of older patients with COPD who smoke. 36 We designed the program to be fully remote and centralized, which allowed us to successfully recruit rural-residing individuals and demonstrate feasibility for this often hard to reach population. While the protocol was designed to be motivational it was notable that while more participants in the intervention arm engaged with cessation supports, there was no observed effect on quit attempts or change in the quit ladder. This suggests that the utility of the program may be primarily ease of connection to treatment for otherwise motivated individuals, rather than an effect on motivation per se. It is notable that despite many participants reporting no timeframe to quit at baseline, many of these individuals did in fact use assistance, attempt to quit smoking, or change their smoking behaviors over 6 months of follow-up. Unsurprisingly, more participants intending to quit at baseline successfully became abstinent from tobacco. Our results support that motivation to quit can change rapidly over time. Far from being refractory to cessation support, patients with COPD who smoke, even who state they are not planning to quit, made frequent supported quit attempts and were open to engaging in tobacco treatment. Longitudinal outreach programs such as this one can capitalize on this shifting motivation to engage patients in supported quit attempts. In our preliminary work, we found that navigating technology to access care was a common source of frustration 36 and patients preferred live phone care to automated systems. Clinicians perceived the same preferences and strongly recommended that proactive programs incorporate live phone calls whenever possible. 24 However, the burden to the health system associated with exclusively live phone outreach is a barrier to implementation. Therefore, we chose a ‘hybrid’ approach, combining automated text outreach with phone-based care coordination for interested individuals, which was successful in connecting patients to care. Patients and clinicians also prefer to have choices when accessing tobacco treatments. In our prior work, clinicians perceive that patients’ lack of knowledge that there are choices is a barrier to cessation participation, particularly for patients with past experience with quit support that was unsuccessful. We therefore explicitly offered participants a choice of care, rather than an automatic referral. While these approaches increased the complexity beyond that of a fully technology-based intervention, the trade-off appears justified by the high acceptability and increased uptake of combined pharmacologic and behavioral treatments. Future work could compare the hybrid approach text-based outreach with phone coordination) with fully automatic options. Previous studies have provided proactive outreach using a variety of modalities and intensities and our findings align with these results. In a randomized study of mailed vs phone-based outreach with free nicotine replacement offered to low-income individuals who smoke, at one year more individuals in the outreach arm had quit (16.5% vs 12.5%) and used combined behavioral and pharmacologic treatment (17.4% vs 3.6%), similar to what we observed. 37 Another four-arm study compared the impact of brief phone advice vs mailed NRT alone vs mailed NRT and text messaging vs usual care on short-term cessation behaviors at 12 weeks, finding that more participants in the texting, NRT, and combined texting and NRT arms attempted to quit, with positive effects on 7-day abstinence. However, they found no differences between the three intervention arms. 38 A large study (5,123) of Veterans in primary care compared usual care to a mailed + phone offer of cessation services (counseling by phone or in person) finding increased prolonged cessation at one year (13.5% vs 10.9%) and increased treatment utilization 39 in the intervention arm. Another study examining 3 monthly mailed offers of cessation services (10% acceptance of treatment, 5.3 vs 1.1% 7-day abstinence at 3 months 21 ) found fairly similar effects as our program. When formally assessed, all proactive outreach interventions have been found to be cost-effective well below usual thresholds. 40 While we did not assess the cost in this pilot, the overall cost of the intervention is expected to be low and would be expected to be similar to prior programs. To minimize costs and enhance scalability, we elected to use a clinically available texting platform and tailor it to our target patient population. We found a moderate rate of system errors (5/83, 6%) resulting in the protocol being terminated early. A greater concern was that some participants struggled to conform to the response format required by texting system, resulting either in discharge from the protocol or failure of an attempted response to be recorded. Our participants included a significant proportion with low electronic health literacy. In our preliminary work, 36 very few patients with COPD who smoke had ever used any sort of text messaging program or health-related app. This lack of experience likely explains their challenges with the system. In future iterations of the texting protocol, we plan to simplify the required responses (eg, a single number or letter response). We plan to include more ‘training’ messages up front about how to interact with the system. We hope to incorporate more personalized options in the program, for example allowing participants who want to continue to opt for ongoing messaging, and to streamline the process of contacting the team for care coordination. The requirement to contact patients by phone or in person prior to enrolling them in the program is a limitation to broad uptake. We are currently working on improving the program in preparation for a larger-scale multisite study, considering alternative strategies for recruitment such as clinic-based outreach and enrollment. Our study has limitations. This was a small, single center pilot including mostly white, male Veterans. Results may therefore not be generalizable to other settings and should be replicated on a larger scale. However, this is a group expected to be particularly refractory to treatment suggesting that a similar protocol would work as well or better in other healthcare settings. We chose to make relatively moderate adaptations to an existing protocol and there may have been other areas that would have benefitted from further tailoring. We identified several areas that would benefit from refinement, including ‘dropping’ of participants, and plan to make these changes for further research and clinical use. Outcomes were relatively short and measured by self-report. As this was a pilot study, sample size was determined by precision of estimates and we were underpowered for statistical significance. There was baseline imbalance in no intention to quit, which was adjusted for by statistical means. If anything, this strengthens the results given that this is a population particularly refractory to cessation. Conclusion In conclusion, we found that a proactive motivational texting program with phone-based care coordination was feasible and acceptable for patients with COPD who smoke and may result in increased use of cessation resources. Such a protocol is suitable for implementation in many clinical settings including pulmonary clinics where patients could be enrolled at or around a planned visit. Future research will test the protocol on a broader scale and integrate further improvements to increase the usability of the texting interface. Acknowledgements The authors would like to acknowledge Lara Carson for her invaluable help tailoring the texting protocol. Care Coordination Script To be used when a veteran requests care coordination though either the Annie app or call. Hello, this is ____________ calling you back from the Minneapolis VA tobacco team. Thank you for contacting us about help stopping smoking. We’re excited to hear from you and to help connect you with resources. I’d like to start by asking, tell me more about why it is important to you to quit smoking? (Reflect back the importance of these reasons). What have you tried in the past? Has anything been particularly helpful? (if they have attempted prior): It’s great that you____________ (reflect their experiences. Eg, “It’s great that you were able to quit for 2 days while you were in the hospital.” “It sounds like you still had cravings using the nicotine replacement, but it’s great that you were motivated to try to quit using support. Sometimes a higher dose or a different medication is needed.). It takes most people many tries to quit and you are taking a great step reaching out today. (If no) Wow, you are taking a really huge and important step by reaching out today, it’s great that you are interested in trying now. The VA offers some great options to help people stop smoking. We can find something to fit all needs and schedules. Can I give you some information on the options available? There are several options available through the Minneapolis VA and through the national VA. It is important to find a program that combines medications, which help manage the physical cravings, with counseling to help change habits. First, I would like to ask, are you working with a mental health provider? (if Yes) Would it be ok if I reached out to them to discuss your interest in quitting smoking? (include if either answer yes or no) One really great option is to enroll in a stop smoking class. We have a class here run by a pharmacist, psychologist, and peer support specialist. Classes can also help by learning from and supporting other Veterans who are also working to quit smoking. Right now, most classes are being done virtually or over the phone and meet about once a week. Does this sound like something you are interested in? (if yes): Great, I will place that referral and someone will contact you. (if no): Another option is to work with your pharmacist. Your pharmacist is a trained expert in quit support and can help with medication management and give you individual strategies to help you quit. Medications can be nicotine replacement or prescriptions medications. It can be helpful to also work with a counselor from the Quitline to make sure you have all the help you need. Can I refer you to your pharmacist for assistance? (if yes): Great, I will place that referral and someone will contact you. (go on to discuss the Quitline). (if no) The VA offers a Quitline just for Veterans. We’ve seen some really great success with Veterans who have connected with the Quitline and followed through with the process. These are professionals whose full-time job is helping people stop using tobacco, so they are excellent at what they do. We will sign you up with the Quitline and they will contact you. Can I set you up with a quit counselor? (if yes): Great! I will place that referral, and someone will contact you. (if they did not select pharmacist medication management above): We will also let your primary care provider know, so they can help you with medications. If none of the above: OK. The VA also offers a stop smoking “app” for Veterans, particularly tailored for Veterans trying to quit smoking while dealing with PTSD. You need to have a smartphone or tablet to access this. The app provides education and helps walk you through some ways to set goals and change behaviors. If you are interested, I can help you sign up. (if yes): Great! I will walk you through signing up. (Assist with downloading and enrollment through the app store). (if no) The VA also offers a text messaging program that can be very helpful. This program offers information and education about stopping smoking and also helps walk you through changing behaviors or setting goals. I can help sign you up for that program. (if yes): Great, I will need to ask you a few questions to get you signed up (Assist with signing up through https://smokefreevet.gov). If app or texting is chosen: Great! I will also send a message to your primary care provider to let them know you are interested in quitting smoking so they can help you with medications and support. If declines all options: “On a scale of 1-10, how important is it to you to quit smoking?ˮ (if 2-10), Can you tell me why you are a __ and not a 1 or a 2? (Staff will reflect back their reasons: Example: “So on the one hand, you’re worried that it could add to your stress to quit, but on the other hand, you think smoking is really increasing your stress in other ways… like financially and on your health. Would it be okay if I shared some information about a program we have to help manage stress?”) Coordinator may offer stress management program and a call back in a month to discuss options again. Acronym Sheet Chronic obstructive pulmonary disease Control arm Electronic health record Information and communication technology Intervention arm Minneapolis VA health care system Nicotine replacement therapy Tobacco dependence treatment Veterans affairs. Author Contributions: AM obtained funding, wrote protocol, completed primary manuscript drafting and is the overall guarantor of study findings. MC assisted in protocol development, completed data collection, and assisted in manuscript drafting. AK and DN designed and completed statistical analysis, assisted in data interpretation and manuscript drafting. SF and HH contributed to project and protocol development, interpreted data, and participated in manuscript drafting. Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by a Department of Veterans Affairs (VA) Health Systems Research Career Development Award to Dr Melzer (VA HSR CDA HX003067-01A1). Funder had no role in design or conduct of the study. The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Guarantor: Dr Melzer takes responsibility for the content of this manuscript, including data and analysis. IRB Approval: This study was approved by the IRB (#1708415) with a waiver of documentation of informed consent and registered on https://www.clinicaltrials.gov (NCT04462289). Disclaimer: The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. Prior Abstract Publication/Presentation: A portion of these results were presented in abstract form at the American Thoracic Society meeting May 2025. ORCID iD Anne C. Melzer https://orcid.org/0000-0001-6966-7848 Data Availability Statement De-identified data can be shared on reasonable request to the principal investigator.* References Associated Data Data Availability Statement De-identified data can be shared on reasonable request to the principal investigator.*